Company / Profit Margin
BIOCRYST PHARMACEUTICALS INC Profit Margin History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-261.2%
FY2017
5-year range
-
FY2016-FY2017
Trend
-24.8%
vs FY2016
Sector context
#114 of 145
Health Care
What the data says
BIOCRYST PHARMACEUTICALS INC's profit margin of -261.2% is lower than 79% of companies in the Health Care sector (FY2017).
Based on SEC 10-K filings.
-261.2% in FY2017.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 145This company -261.2% Sector average -792.7%
▼
+67.1% above sector average
Key checks
Key Insights
- In FY2017, profit margin decreased 24.8% year-over-year.
- Currently 531.5pp above the Health Care sector average.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | -261.2% | -24.8% |
| FY2016 | -209.2% | -134.7% |
As of FY2017 · SEC 10-K · Updated Jun 30, 2026